Lack of efficacy of dual intragastric balloon therapy on weight loss and patient dissatisfaction.

Document Type

Article

Publication Date

3-1-2021

Publication Title

American journal of surgery

Abstract

BACKGROUND: Dual intragastric balloon (DIGB) therapy is a non-surgical, restrictive method of weight loss. We evaluated weight loss and patient satisfaction after DIGB removal.

METHODS: Between 2016 and 2019, 35 patients had DIGB therapy. A retrospective review of weight loss at balloon removal and follow-up, adverse events during DIGB therapy, and patient satisfaction was performed.

RESULTS: At follow-up after balloon removal (22.3 ± 10.5 months), mean percent excess weight loss (%EWL) was significantly decreased compared to %EWL at removal (4.7 ± 42.7% vs 32.4 ± 38.8%, p = .001). Weight regain occurred in 22/31 (71%) patients. Adverse events during DIGB therapy included: nausea, abdominal pain, reflux, pancreatitis, and gastric outlet obstruction. Twenty-five (71.4%) patients completed a satisfaction questionnaire. Only 3/25 (12%) patients were satisfied, and 92% would not choose DIGB for weight loss.

CONCLUSION: Weight loss achieved from DIGB on average was not maintained after balloon removal. Most patients were not satisfied and would not choose DIGB again.

Volume

221

Issue

3

First Page

581

Last Page

584

DOI

10.1016/j.amjsurg.2020.11.010

ISSN

1879-1883

PubMed ID

33190789

Link to Full Text

Share

COinS